1O Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab.

Details

Language :

English

ISSN :

15560864

Volume :

13

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

129335221

Full Text :

https://doi.org/10.1016/S1556-0864(18)30281-8